JP6590589B2 - 血小板機能の測定方法 - Google Patents
血小板機能の測定方法 Download PDFInfo
- Publication number
- JP6590589B2 JP6590589B2 JP2015165635A JP2015165635A JP6590589B2 JP 6590589 B2 JP6590589 B2 JP 6590589B2 JP 2015165635 A JP2015165635 A JP 2015165635A JP 2015165635 A JP2015165635 A JP 2015165635A JP 6590589 B2 JP6590589 B2 JP 6590589B2
- Authority
- JP
- Japan
- Prior art keywords
- platelets
- electric field
- platelet
- stimulant
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims description 19
- 230000033001 locomotion Effects 0.000 claims description 36
- 230000005684 electric field Effects 0.000 claims description 32
- 239000002245 particle Substances 0.000 claims description 12
- 238000001997 free-flow electrophoresis Methods 0.000 claims description 9
- 230000009471 action Effects 0.000 claims description 8
- 238000001514 detection method Methods 0.000 claims description 3
- XTWYTFMLZFPYCI-KQYNXXCUSA-N 5'-adenylphosphoric acid Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XTWYTFMLZFPYCI-KQYNXXCUSA-N 0.000 claims description 2
- BSYNRYMUTXBXSQ-FOQJRBATSA-N 59096-14-9 Chemical compound CC(=O)OC1=CC=CC=C1[14C](O)=O BSYNRYMUTXBXSQ-FOQJRBATSA-N 0.000 claims description 2
- XTWYTFMLZFPYCI-UHFFFAOYSA-N Adenosine diphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(O)=O)C(O)C1O XTWYTFMLZFPYCI-UHFFFAOYSA-N 0.000 claims description 2
- 239000005552 B01AC04 - Clopidogrel Substances 0.000 claims description 2
- 239000005465 B01AC22 - Prasugrel Substances 0.000 claims description 2
- 102000008186 Collagen Human genes 0.000 claims description 2
- 108010035532 Collagen Proteins 0.000 claims description 2
- 108090000190 Thrombin Proteins 0.000 claims description 2
- 229960003009 clopidogrel Drugs 0.000 claims description 2
- GKTWGGQPFAXNFI-HNNXBMFYSA-N clopidogrel Chemical compound C1([C@H](N2CC=3C=CSC=3CC2)C(=O)OC)=CC=CC=C1Cl GKTWGGQPFAXNFI-HNNXBMFYSA-N 0.000 claims description 2
- 229920001436 collagen Polymers 0.000 claims description 2
- 108010089485 convulxin Proteins 0.000 claims description 2
- KAQKFAOMNZTLHT-VVUHWYTRSA-N epoprostenol Chemical compound O1C(=CCCCC(O)=O)C[C@@H]2[C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C[C@@H]21 KAQKFAOMNZTLHT-VVUHWYTRSA-N 0.000 claims description 2
- 229960001123 epoprostenol Drugs 0.000 claims description 2
- 230000003287 optical effect Effects 0.000 claims description 2
- 229960004197 prasugrel Drugs 0.000 claims description 2
- DTGLZDAWLRGWQN-UHFFFAOYSA-N prasugrel Chemical compound C1CC=2SC(OC(=O)C)=CC=2CN1C(C=1C(=CC=CC=1)F)C(=O)C1CC1 DTGLZDAWLRGWQN-UHFFFAOYSA-N 0.000 claims description 2
- 150000003180 prostaglandins Chemical class 0.000 claims description 2
- 229960004072 thrombin Drugs 0.000 claims description 2
- 238000002059 diagnostic imaging Methods 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 239000007788 liquid Substances 0.000 description 5
- 239000013543 active substance Substances 0.000 description 4
- 239000000556 agonist Substances 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 239000000021 stimulant Substances 0.000 description 3
- 230000004913 activation Effects 0.000 description 2
- 230000004931 aggregating effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000024659 Hemostatic disease Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 229910002804 graphite Inorganic materials 0.000 description 1
- 239000010439 graphite Substances 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000003076 paracrine Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 238000013166 platelet test Methods 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000012146 running buffer Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5032—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on intercellular interactions
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
- G01N27/447—Systems using electrophoresis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
- G01N33/4915—Blood using flow cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N2015/1006—Investigating individual particles for cytology
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Ecology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Electrochemistry (AREA)
- Dispersion Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE201410112270 DE102014112270B3 (de) | 2014-08-27 | 2014-08-27 | Verfahren zur Messung der Thrombozytenfunktion |
DE102014112270.4 | 2014-08-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2016048236A JP2016048236A (ja) | 2016-04-07 |
JP6590589B2 true JP6590589B2 (ja) | 2019-10-16 |
Family
ID=52775479
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015165635A Active JP6590589B2 (ja) | 2014-08-27 | 2015-08-25 | 血小板機能の測定方法 |
Country Status (6)
Country | Link |
---|---|
US (1) | US9778248B2 (de) |
EP (1) | EP2990787B1 (de) |
JP (1) | JP6590589B2 (de) |
CN (1) | CN105388202B (de) |
DE (1) | DE102014112270B3 (de) |
ES (1) | ES2637317T3 (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014062719A2 (en) | 2012-10-15 | 2014-04-24 | Nanocellect Biomedical, Inc. | Systems, apparatus, and methods for sorting particles |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE59108006D1 (de) * | 1991-01-28 | 1996-08-22 | Ciba Geigy Ag | Vorrichtung zur Vorbereitung von Proben insbesondere für Analysezwecke |
US6432630B1 (en) * | 1996-09-04 | 2002-08-13 | Scandinanian Micro Biodevices A/S | Micro-flow system for particle separation and analysis |
US7699767B2 (en) * | 2002-07-31 | 2010-04-20 | Arryx, Inc. | Multiple laminar flow-based particle and cellular separation with laser steering |
BR0313130A (pt) * | 2002-07-31 | 2007-07-17 | Arryx Inc | método e aparelho de classificação de objetos; método de manipulação de objetos; método de destruição de objetos; e aparelho para destruir objetos |
GB0313197D0 (en) * | 2003-06-09 | 2003-07-16 | Imp College Innovations Ltd | Free flow electrophoresis microchip, system and method |
US20070243632A1 (en) * | 2003-07-08 | 2007-10-18 | Coller Barry S | Methods for measuring platelet reactivity of patients that have received drug eluting stents |
US7771660B2 (en) * | 2004-05-04 | 2010-08-10 | University Of North Carolina At Chapel Hill | Electrophoretic interactive spectral methods and devices for the detection and/or characterization of biological particles |
EP1742057A1 (de) * | 2005-07-08 | 2007-01-10 | Stichting Voor De Technische Wetenschappen | Vorrichtung und Verfahren zur Partikeltrennung |
JP2007101289A (ja) * | 2005-10-03 | 2007-04-19 | Furuido:Kk | マイクロ流体デバイスおよびこれを用いた生体物質検査装置とマイクロ化学リアクター |
TW201017149A (en) * | 2008-08-06 | 2010-05-01 | Invitrox Inc | Use of focused light scattering techniques in biological applications |
US9404933B2 (en) * | 2011-07-21 | 2016-08-02 | Invitrox, Inc. | Methods for determining patient response to anti-platelet aggregation therapy |
-
2014
- 2014-08-27 DE DE201410112270 patent/DE102014112270B3/de not_active Expired - Fee Related
-
2015
- 2015-08-13 EP EP15180931.6A patent/EP2990787B1/de active Active
- 2015-08-13 ES ES15180931.6T patent/ES2637317T3/es active Active
- 2015-08-25 JP JP2015165635A patent/JP6590589B2/ja active Active
- 2015-08-26 US US14/835,834 patent/US9778248B2/en active Active
- 2015-08-27 CN CN201510534868.4A patent/CN105388202B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
JP2016048236A (ja) | 2016-04-07 |
US9778248B2 (en) | 2017-10-03 |
EP2990787A1 (de) | 2016-03-02 |
US20160061819A1 (en) | 2016-03-03 |
CN105388202A (zh) | 2016-03-09 |
CN105388202B (zh) | 2019-08-13 |
ES2637317T3 (es) | 2017-10-11 |
DE102014112270B3 (de) | 2015-04-23 |
EP2990787B1 (de) | 2017-05-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zheng et al. | Electrical measurement of red blood cell deformability on a microfluidic device | |
Zheng et al. | Recent advances in microfluidic techniques for single-cell biophysical characterization | |
US9378557B2 (en) | Microfluidic device for assessing object/test material interactions | |
Reale et al. | High-throughput electrical position detection of single flowing particles/cells with non-spherical shape | |
US20100170796A1 (en) | In Vitro Microfluidic Model of Microcirculatory Diseases, and Methods of Use Thereof | |
Maji et al. | Assessment of whole blood coagulation with a microfluidic dielectric sensor | |
US20160047827A1 (en) | Apparatus for Analyzing the Process of Formation of Aggregates in a Biological Fluid and Corresponding Method of Analysis | |
US8895312B2 (en) | Nanofluidic platform for single mitochondria analysis | |
JP6590589B2 (ja) | 血小板機能の測定方法 | |
Kaliviotis et al. | Erythrocyte aggregation at non-steady flow conditions: A comparison of characteristics measured with electrorheology and image analysis | |
EP2845002B1 (de) | Verfahren zur analyse eines clusterbildungsverfahrens in einer biologischen flüssigkeit und entsprechende analysevorrichtung | |
RU86317U1 (ru) | Устройство для определения микрообъемов крови | |
US20230221341A1 (en) | Method for evaluating the metabolic activity of a non-cancer cell | |
RU164923U1 (ru) | Картридж для анализа индуцированной агрегации тромбоцитов крови методом импедансной агрегометрии | |
KR102019007B1 (ko) | 센서집적형 장기칩 | |
RU2441235C1 (ru) | Способ оценки деформируемости клеток крови и устройство для его реализации | |
Yang et al. | A single high-intensity nanosecond electric pulse stimulates NALCN and TRPC4/5 channels leading to Na+ accumulation in adrenal chromaffin cells as detected by live cell Na+ fluorescence imaging | |
Anderson et al. | Analyzing small molecule and polymer events in a protein nanopore for paired optical and electrical measurements | |
Ahmed et al. | A novel activator of Piezo1: Wound healing assay | |
Ali et al. | OMEF biochip for evaluating red blood cell deformability using dielectrophoresis as a diagnostic tool for type 2 diabetes mellitus | |
Zhao | Nanofluidics: Transport in chirality-controlled carbon nanotube porins (CNTPs) and fluorescence ultrashort nanotubes (FUNs) | |
Mancuso | Red Blood Cell Stretching Behavior and Mechanotransduction | |
JP2024094350A (ja) | Chemfetセンサーアレイベースのシステムを用いた細胞分析 | |
Zheng | Microfluidic systems for highthroughput biophysical characterization of single cells | |
UA30359U (uk) | Спосіб діагностики донозологічного стану в чоловіків |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20180314 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20181219 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20181226 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190320 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20190828 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20190917 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6590589 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |